Tadalafil COA — Verified Certificate of Analysis Results
51 independent third-party certificates of analysis for Tadalafil, from 2 labs across 34 vendors (2017-11-13 to 2026-06-15).
Every Tadalafil certificate of analysis below is from an independent third-party lab, ingested and verified by TitrateLab. The figures here are computed live from the 51 published Tadalafil certs in our corpus.
Assay metrics
Tadalafil lab-testing metrics
98%
Median tested purity
0
Zero-purity certs
Mean purity97.8%
Mean dose vs label+15.5%
Within 10% of label dose67%
Overdosed ≥ +7%36%
Underdosed ≤ −7%7%
COAs per testing lab
Every lab testing Tadalafil in the corpus.
Tested-purity distribution
Bins below 90% tested purity.
| Purity range | Certificates |
|---|---|
| 0–50% | 0 |
| 50–70% | 0 |
| 70–80% | 0 |
| 80–85% | 0 |
| 85–90% | 0 |
| 90–91% | 0 |
| 91–92% | 0 |
| 92–93% | 0 |
| 93–94% | 0 |
| 94–95% | 0 |
| 95–96% | 0 |
| 96–97% | 3 |
| 97–98% | 0 |
| 98–99% | 4 |
| 99–100% | 2 |
COAs over time
Tadalafil certificates published per month.
| Month | Certificates |
|---|---|
| 2017-11 | 1 |
| 2018-12 | 1 |
| 2019-08 | 1 |
| 2020-01 | 1 |
| 2020-06 | 1 |
| 2020-12 | 1 |
| 2021-02 | 1 |
| 2021-05 | 1 |
| 2021-07 | 1 |
| 2021-10 | 1 |
| 2022-07 | 1 |
| 2022-08 | 1 |
| 2022-11 | 2 |
| 2022-12 | 3 |
| 2023-01 | 1 |
| 2023-03 | 3 |
| 2023-04 | 1 |
| 2023-05 | 2 |
| 2023-08 | 2 |
| 2024-01 | 2 |
| 2024-04 | 1 |
| 2024-05 | 1 |
| 2024-07 | 2 |
| 2024-08 | 3 |
| 2024-10 | 3 |
| 2024-12 | 1 |
| 2025-01 | 1 |
| 2025-04 | 2 |
| 2025-05 | 1 |
| 2025-08 | 2 |
| 2025-10 | 1 |
| 2026-02 | 2 |
| 2026-05 | 1 |
| 2026-06 | 2 |
Most-tested vendors
Top 10 of 15 vendors by Tadalafil certificate count.
See who tests most — unlock the vendor names with Pro.
+ 5 more vendors with fewer certificates.
Verified Tadalafil certificates of analysis
51 records. Zero guesswork.
Unlock the actual vendor, purity, dose accuracy, lab, batch and saved certificate for every Tadalafil result.
Sign in to viewIllustrative structure only. No record-level values are present in this preview.